Moderna MRNA is expected to report first-quarter 2025 earnings on May 1, before the opening bell. The company’s earnings beat ...

Talus Bioscience, a technology-enabled therapeutics company, today announced new preclinical data from programs targeting transcription factors in chordoma, non-small cell lung cancer, and advanced ...

RNA-based technologies are a powerful molecular biology toolbox, empowering scientists to decipher the complexities of living ...

Historically, the vast majority of pharmaceutical drugs have been meticulously designed down to the atomic level. The ...

Business interests and intellectual property laws privilege the wealthy and leave the rest scrabbling for life-saving ...

The global vulvovaginal candidiasis treatment market is currently valued at USD 1035 million in 2023 and is anticipated to expand at a CAGR of 4.5%. Owing to the technological advances in healthcare ...

A scientific revolution is underway as researchers push to bring atomic-level precision, once reserved for small molecule ...

Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company ...

This episode of Drug Digest will discuss where the significant bottlenecks are in the development and manufacturing of new ...